Stanley Lau - Jul 31, 2023 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Role
Director
Signature
/s/ Elisa Luqman as attorney-in-fact for Stanley Lau
Stock symbol
CDIO
Transactions as of
Jul 31, 2023
Transactions value $
$0
Form type
4
Date filed
10/4/2023, 12:15 PM
Previous filing
Jul 5, 2023
Next filing
Nov 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDIO Common Stock Options Exercise $2K +1.65K +5.62% $1.21 31.1K Jul 31, 2023 Direct F1
transaction CDIO Common Stock Options Exercise $2K +3.64K +11.71% $0.55 34.7K Aug 31, 2023 Direct F2
transaction CDIO Common Stock Options Exercise $2K +5.88K +16.95% $0.34 40.6K Sep 30, 2023 Direct F3
transaction CDIO Common Stock Options Exercise $12.5K +36.8K +90.59% $0.34 77.3K Sep 30, 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDIO Restricted Stock Units Options Exercise -$2K $12K Jul 31, 2023 Common Stock $2K $0.00 Direct F5, F6, F7
transaction CDIO Restricted Stock Units Options Exercise -$2K $10K Aug 31, 2023 Common Stock $2K $0.00 Direct F6, F7, F8
transaction CDIO Restricted Stock Units Options Exercise -$2K $8K Sep 30, 2023 Common Stock $2K $0.00 Direct F6, F7, F9
transaction CDIO Restricted Stock Units Options Exercise -$12.5K $12.5K Sep 30, 2023 Common Stock $12.5K $0.00 Direct F7, F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on July 31, 2023 through the issuance of shares of Common Stock.
F2 Represents the settlement of RSUs, awarded for advisory services, which vested on August 31, 2023 through the issuance of shares of Common Stock
F3 Represents the settlement of RSUs, awarded for advisory services, which vested on September 30, 2023 through the issuance of shares of Common Stock.
F4 Represents the settlement of RSUs, awarded as director compensation, which vested on September 30, 2023 through the issuance of shares of Common Stock.
F5 Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On July 31, 2023, $2,000 in value of RSUs vested and were settled at the price of $1.21, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
F6 On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024.
F7 The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.
F8 Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On August 31, 2023, $2,000 in value of RSUs vested and were settled at the price of $0.5499, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.
F9 Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $2,000 in value of RSUs vested and were settled at the price of $0.34 which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.
F10 Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34 which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.
F11 On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.